methyl 2-(4-chlorophenyl)-2-(3-(4-chlorophenyl)-5-oxo-8-((thiophen-3-ylmethyl)amino)-2-thioxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-4(5H)-yl)acetate | 1345870-64-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methyl 2-(4-chlorophenyl)-2-(3-(4-chlorophenyl)-5-oxo-8-((thiophen-3-ylmethyl)amino)-2-thioxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-4(5H)-yl)acetate
• 英文别名: Methyl 2-(4-chlorophenyl)-2-[3-(4-chlorophenyl)-5-oxo-2-sulfanylidene-8-(thiophen-3-ylmethylamino)-1,3-dihydro-1,4-benzodiazepin-4-yl]acetate
• CAS: 1345870-64-5
• 化学式: C₂₉H₂₃Cl₂N₃O₃S₂
• 分子量: 596.558
• InChiKey: ORQSRWQAMDJMDY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.7
• 重原子数：
  39
• 可旋转键数：
  8
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  131
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  2,4-二硝基苯甲酸 在 劳森试剂 、 溶剂黄146 、 potassium hydroxide 作用下， 以 甲醇 、 甲苯 为溶剂， 反应 20.67h， 生成 methyl 2-(4-chlorophenyl)-2-(3-(4-chlorophenyl)-5-oxo-8-((thiophen-3-ylmethyl)amino)-2-thioxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-4(5H)-yl)acetate
  参考文献：
  名称：

  Synthesis and biological evaluation of thio-benzodiazepines as novel small molecule inhibitors of the p53–MDM2 protein–protein interaction

  摘要：

  A series of thio-benzodiazepine p53-MDM2 inhibitors were designed and synthesized based on the principle of bioisosterism. Most of the thio-benzodiazepines had nanomolar to micromolar affinity toward MDM2. Particularly, compounds 8a (K-i = 0.52 mu M) and 8f (K-i = 0.32 mu M) showed binding activity comparable to the positive drug nutlin-3a (K-i = 0.23 mu M). Meanwhile, compound 8j exhibited excellent antitumor activity against the U-2 OS human osteosarcoma cell line with an IC50 value of 1.06 mu M, which was about 23 times higher than that of nutlin-3a. The docking model also successfully predicted that this class of compounds mimicked three p53 critical residues binding to MDM2. The thio-benzodiazepines represent a promising class of non-peptide inhibitors of the p53-MDM2 interaction. (C) 2011 Published by Elsevier Masson SAS.

  DOI：

  10.1016/j.ejmech.2011.09.043

文献信息

• Synthesis and biological evaluation of thio-benzodiazepines as novel small molecule inhibitors of the p53–MDM2 protein–protein interaction
  作者：Chunlin Zhuang、Zhenyuan Miao、Lingjian Zhu、Yongqiang Zhang、Zizhao Guo、Jianzhong Yao、Guoqiang Dong、Shengzheng Wang、Yang Liu、Hai Chen、Chunquan Sheng、Wannian Zhang

  DOI：10.1016/j.ejmech.2011.09.043

  日期：2011.11

  A series of thio-benzodiazepine p53-MDM2 inhibitors were designed and synthesized based on the principle of bioisosterism. Most of the thio-benzodiazepines had nanomolar to micromolar affinity toward MDM2. Particularly, compounds 8a (K-i = 0.52 mu M) and 8f (K-i = 0.32 mu M) showed binding activity comparable to the positive drug nutlin-3a (K-i = 0.23 mu M). Meanwhile, compound 8j exhibited excellent antitumor activity against the U-2 OS human osteosarcoma cell line with an IC50 value of 1.06 mu M, which was about 23 times higher than that of nutlin-3a. The docking model also successfully predicted that this class of compounds mimicked three p53 critical residues binding to MDM2. The thio-benzodiazepines represent a promising class of non-peptide inhibitors of the p53-MDM2 interaction. (C) 2011 Published by Elsevier Masson SAS.